NI201000069A - Composiciones para inhalación que comprenden ácido de monteleukast y un inhibidor pde-4 o un corticosteroide inhalado. - Google Patents
Composiciones para inhalación que comprenden ácido de monteleukast y un inhibidor pde-4 o un corticosteroide inhalado.Info
- Publication number
- NI201000069A NI201000069A NI201000069A NI201000069A NI201000069A NI 201000069 A NI201000069 A NI 201000069A NI 201000069 A NI201000069 A NI 201000069A NI 201000069 A NI201000069 A NI 201000069A NI 201000069 A NI201000069 A NI 201000069A
- Authority
- NI
- Nicaragua
- Prior art keywords
- acid
- compositions
- monteleukast
- inhaled corticosteroid
- inhalation including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona composiciones para inhalación que comprenden ácido montelukast y un segundo agente activo seleccionado de un inhibidor de PDE-4 y un corticoesteroide inhalado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32707P | 2007-10-25 | 2007-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
NI201000069A true NI201000069A (es) | 2010-08-23 |
Family
ID=40579006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI201000069A NI201000069A (es) | 2007-10-25 | 2010-04-22 | Composiciones para inhalación que comprenden ácido de monteleukast y un inhibidor pde-4 o un corticosteroide inhalado. |
Country Status (19)
Country | Link |
---|---|
US (1) | US20100210611A1 (es) |
EP (1) | EP2211863A4 (es) |
JP (1) | JP2011500731A (es) |
KR (1) | KR20100072295A (es) |
CN (1) | CN101909626A (es) |
AU (1) | AU2008316283A1 (es) |
CA (1) | CA2701956A1 (es) |
CO (1) | CO6270213A2 (es) |
CR (1) | CR11439A (es) |
DO (1) | DOP2010000122A (es) |
GT (1) | GT201000107A (es) |
IL (1) | IL205182A0 (es) |
MA (1) | MA33705B1 (es) |
MX (1) | MX2010004529A (es) |
NI (1) | NI201000069A (es) |
NZ (1) | NZ584876A (es) |
RU (1) | RU2470639C2 (es) |
WO (1) | WO2009052624A1 (es) |
ZA (1) | ZA201002562B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012168907A1 (en) | 2011-06-10 | 2012-12-13 | Glenmark Pharmaceuticals Sa | Pharmaceutical composition comprising revamilast and montelukast or zafirlukast |
WO2014012954A1 (en) | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
JP2017503814A (ja) | 2014-01-22 | 2017-02-02 | タケダ ゲー・エム・ベー・ハーTakeda GmbH | 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のpde4インヒビターを用いた(およびロイコトリエン調節薬と組み合わせて用いた)治療 |
CN108267531B (zh) * | 2016-12-31 | 2022-01-11 | 天津金耀集团有限公司 | 一种环索奈德有关物质hplc测定方法 |
IT201900014178A1 (it) * | 2019-08-06 | 2021-02-06 | Genetic S P A | Esteri del montelukast e loro formulazioni farmaceutiche |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
US20040214805A1 (en) * | 1999-11-02 | 2004-10-28 | Smithkline Beecham Corporation | Method and compositions for treating pulmonary diseases |
AU2002227123A1 (en) * | 2000-11-07 | 2002-05-21 | Merck And Co., Inc. | Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist |
JO2311B1 (en) * | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
IL160272A0 (en) * | 2001-09-19 | 2004-07-25 | Altana Pharma Ag | Pharmaceutical compositions containing a pde4 or a pde3/4 inhibitor and a leukotriene receptor antagonist |
DE10237739A1 (de) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
PL1670482T5 (pl) * | 2003-09-16 | 2022-10-03 | Covis Pharma Gmbh | Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego |
US7553853B2 (en) * | 2003-10-10 | 2009-06-30 | Synthon Bv | Solid-state montelukast |
CA2550848C (en) * | 2004-02-06 | 2013-02-26 | Meda Pharma Gmbh & Co. Kg | Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
EP1616567A1 (en) * | 2004-07-16 | 2006-01-18 | Boehringer Ingelheim Pharma GmbH & Co.KG | Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
BRPI0606283A2 (pt) * | 2005-03-16 | 2009-06-09 | Elan Pharma Int Ltd | formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula |
MX2007011273A (es) * | 2005-03-16 | 2007-11-08 | Meda Pharma Gmbh & Co Kg | La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias. |
EP1931338A4 (en) * | 2005-09-28 | 2009-05-27 | Merck Frosst Canada Inc | AEROSOL POWDER FORMULATION COMPRISING A TAMISED LACTOSE |
-
2008
- 2008-10-23 RU RU2010120806/15A patent/RU2470639C2/ru not_active IP Right Cessation
- 2008-10-23 WO PCT/CA2008/001874 patent/WO2009052624A1/en active Application Filing
- 2008-10-23 US US12/738,946 patent/US20100210611A1/en not_active Abandoned
- 2008-10-23 MX MX2010004529A patent/MX2010004529A/es not_active Application Discontinuation
- 2008-10-23 AU AU2008316283A patent/AU2008316283A1/en not_active Abandoned
- 2008-10-23 KR KR1020107009041A patent/KR20100072295A/ko not_active Application Discontinuation
- 2008-10-23 JP JP2010530233A patent/JP2011500731A/ja active Pending
- 2008-10-23 EP EP08842623A patent/EP2211863A4/en not_active Withdrawn
- 2008-10-23 NZ NZ584876A patent/NZ584876A/en not_active IP Right Cessation
- 2008-10-23 CA CA2701956A patent/CA2701956A1/en not_active Abandoned
- 2008-10-23 CN CN2008801225895A patent/CN101909626A/zh active Pending
-
2010
- 2010-04-13 ZA ZA2010/02562A patent/ZA201002562B/en unknown
- 2010-04-18 IL IL205182A patent/IL205182A0/en unknown
- 2010-04-19 GT GT201000107A patent/GT201000107A/es unknown
- 2010-04-22 CO CO10047531A patent/CO6270213A2/es not_active Application Discontinuation
- 2010-04-22 NI NI201000069A patent/NI201000069A/es unknown
- 2010-04-23 DO DO2010000122A patent/DOP2010000122A/es unknown
- 2010-05-18 CR CR11439A patent/CR11439A/es not_active Application Discontinuation
- 2010-05-20 MA MA32860A patent/MA33705B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2701956A1 (en) | 2009-04-30 |
CN101909626A (zh) | 2010-12-08 |
ZA201002562B (en) | 2011-06-29 |
EP2211863A4 (en) | 2012-07-25 |
WO2009052624A9 (en) | 2010-11-25 |
CO6270213A2 (es) | 2011-04-20 |
JP2011500731A (ja) | 2011-01-06 |
KR20100072295A (ko) | 2010-06-30 |
RU2470639C2 (ru) | 2012-12-27 |
GT201000107A (es) | 2012-03-13 |
MX2010004529A (es) | 2010-05-10 |
AU2008316283A1 (en) | 2009-04-30 |
MA33705B1 (fr) | 2012-11-01 |
WO2009052624A1 (en) | 2009-04-30 |
US20100210611A1 (en) | 2010-08-19 |
IL205182A0 (en) | 2010-11-30 |
NZ584876A (en) | 2012-06-29 |
EP2211863A1 (en) | 2010-08-04 |
DOP2010000122A (es) | 2010-07-15 |
CR11439A (es) | 2010-06-21 |
RU2010120806A (ru) | 2011-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
CY1117751T1 (el) | Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου | |
BR112013012587A2 (pt) | composição farmacêutica para administração nasal | |
CR20110110A (es) | Composicion farmaceutica | |
BR112015029970A2 (pt) | inibidores de cinase | |
BR112015022643A2 (pt) | inibidores diidro-pirrolpiridinona | |
BRPI0907260A2 (pt) | "métodos, dispositivos e composições que liberam óxido nítrico" | |
WO2011002606A8 (en) | Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation | |
SV2009003335A (es) | Formulaciones para el cancer | |
UY31145A1 (es) | Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene | |
NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
TN2009000446A1 (en) | P70 s6 kinase inhibitors | |
DE602006019234D1 (de) | Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen | |
BRPI0718782A2 (pt) | Agente de benefício que contém partícula de liberação | |
HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
IL206529A0 (en) | Antibacterial agent, and device used for active protection of incision margins and incorporating such an antibacterial agent | |
NI201000069A (es) | Composiciones para inhalación que comprenden ácido de monteleukast y un inhibidor pde-4 o un corticosteroide inhalado. | |
CY1115109T1 (el) | Συνθεση αερολυματος για χαπ | |
BR112014010633A2 (pt) | sistema de controle de odor, dispositivo de disseminação programável e cartucho de controle de odor personalizável | |
CR10350A (es) | Mezcla herbicida, que comprende un herbicida de imidazolinona y un adyuvante | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
BR112013030752A2 (pt) | composição de resfriamento e artigo absorvente que compreende a mesma | |
BRPI0608287A2 (pt) | agente endoparasiticida | |
WO2009100886A3 (en) | Formulations of flibanserin | |
UA100296C2 (uk) | Адипонектин для лікування захворювань легенів |